Descripción del título
Bioindustry ethics [David L...
This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics
Monografía
monografia Rebiun05077179 https://catalogo.rebiun.org/rebiun/record/Rebiun05077179 m o d cr cn| 070806s2005 ne ob 001 0 eng d 9780123693709 0123693705 9780080492513 0080492517 UPVA 997186341603706 UAM 991008009805404211 CBUC 991001007129006712 CBUC 991010368277806709 CBUC 991013398921206708 CBUC 991010368277806709 CBUC 991010368277806709 CBUC 991001387309706708 CBUC 991055986799706706 UPCT u296488 OPELS. eng. OPELS. OCLCQ. NT. YDXCP. MERUC. UBY. E7B. IDEBK. OCLCQ. UNAV 174/.96606 22 Bioindustry ethics Recurso electrónico] David L. Finegold ... [et al.]. Amsterdam Boston Elsevier Academic Press c2005 Amsterdam Boston Amsterdam Boston Elsevier Academic Press xi, 368 p. xi, 368 p. EBSCO Academic eBook Collection Complete Incluye índice Incluye referencias bibliográficas e índice Preface -- Introduction -- Leadership -- Starting Right -- Ethics in an Emerging Field -- Getting Advice -- Self-Assessment -- Endnotes This book is the first systematic, detailed treatment of the approaches to ethical issues taken by biotech and pharmaceutical companies. The application of genetic/genomic technologies raises a whole spectrum of ethical questions affecting global health that must be addressed. Topics covered in this comprehensive survey include considerations for bioprospecting in transgenics, genomics, drug discovery, and nutrigenomics, as well as how to improve stakeholder relations, design ethical clinical trials, avoid conflicts of interest, and establish ethics advisory boards. The expert authors represent multiple disciplines including law, medicine, bioinformatics, pharmaceutics, business, and ethics Forma de acceso: World Wide Web Finegold, David